BiotechTube
Home/Metavention/Timothy Mills, Ph.D.
TM

Timothy Mills, Ph.D.

Managing Director, Sanderling Ventures (Board Member)

Metavention

Therapeutic Areas

CardiovascularMetabolic

Metavention Pipeline

DrugIndicationPhase
Hepatic Denervation for Type 2 DiabetesType 2 DiabetesFeasibility
Renal & Hepatic Denervation for HypertensionHypertensionFeasibility
MODUS Multi-Organ Denervation StudyType 2 Diabetes and HypertensionFeasibility

Leadership Team at Metavention

TB
Todd Berg
Independent Director
PM
Pete McNerney
Independent Director
View full Metavention profile